Researchers at the University of Illinois Urbana-Champaign developed oPool+ display, a high-throughput antibody synthesis and specificity characterization platform that can generate and screen hundreds of antibodies simultaneously. The method integrates oligo pool synthesis and mRNA display to evaluate binding across multiple viral antigen variants, drastically reducing the time and cost of traditional antibody discovery. This advancement promises to accelerate therapeutic development against infectious diseases and emerging pathogens.